Close

Jefferies Downgrades VistaGen Therapeutics (VTGN) to Hold

July 22, 2022 11:12 AM EDT
Get Alerts VTGN Hot Sheet
Price: $5.28 +15.54%

Rating Summary:
    6 Buy, 2 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 11 | New: 11
Join SI Premium – FREE

Jefferies analyst Andrew Tsai downgraded VistaGen Therapeutics (NASDAQ: VTGN) from Buy to Hold with a price target of $0.20 (from $8.00).


For an analyst ratings summary and ratings history on VistaGen Therapeutics click here. For more ratings news on VistaGen Therapeutics click here.


Shares of VistaGen Therapeutics closed at $1.07 yesterday.


You May Also Be Interested In





Related Categories

Analyst PT Change, Downgrades